Medical News Feed
German Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Local anaesthetics. |
| Generic Name : | Lidocaine [lignocaine], adrenaline (epinephrine) |
| Drug description : | Solution for injection in cartridges for use in dental-type syringes. |
| Presentation : | Solution for injection, lidocaine hydrochloride monohydrate 24.65mg equivalent to lidocaine base 20mg and adrenaline hydrogen tartrate 25.0 micrograms corresponding to adrenaline 12.5 micrograms. |
| Indications : | Local anaesthetic solution with vasoconstrictor for dental infiltration anaesthesia where a vasoconstrictor is indicated. |
| Adult Dosage : | See data sheet. |
| Child Dosage : | See data sheet. |
| Elderly Dosage : | See data sheet. |
| Contra Indications : | Known hypersensitivity to anaesthetics of the amide type. Not for intravenous use. Contraindicated for anaesthesia of the fingers, toes, tip of nose and penis. |
| Special Precautions : | Epilepsy, cardiac disease Epilepsy, cardiac disease particularly with arrhythmia or hypertension, impaired respiratory function, thyrotoxicosis, hypovolaemia, acute porphyria and impaired hepatic function. Pregnancy and lactation. Avoid accidental intravascular injection. |
| Interactions : | Tricyclic antidepressants. |
| Adverse Reactions : | Reactions primarily of two types, typified by stimulation and depression of the cerebral cortex and medulla, respectively. Slow onset - stimulation leading to nervousness, dizziness, blurred vision, nausea, tremor, convulsions and respiratory arrest. Rapid onset - depression leading primarily to respiratory arrest, cardiovascular collapse and cardiac arrest. |
| Manufacturer : | AstraZeneca |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org